Intimation of newspaper advertisement by Novartis India Limited (''the Company'') regarding the publication of Unaudited Financial Results of the Company for the quarter ended December 31, 2025.
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India has informed BSE that its unaudited financial results for the quarter and nine months ended December 31, 2025 were published in newspaper advertisements on January 29, 2026 in Financial Express (English) and Navshakti (Marathi), as required under SEBI LODR Regulation 47. From the published extract, total income for the quarter stood at Rs. 123.4 million and for the nine months at Rs. 254.5 million, with net profit after tax of Rs. 27.51 million and EPS of Rs. 6.52 for the quarter. The results include a prior-year tax expense of Rs. 55.6 million spread across assessment years 2015-16, 2011-12, 2023-24 and 2025-26. The filing is signed by Company Secretary Chandni Maru and is purely a regulatory intimation confirming publication of the already-filed results.
This is a routine compliance filing — the underlying results were already filed with the exchanges earlier under Regulation 33, so no new information for shareholders. The one-time tax adjustment relating to older assessment years is a minor disclosure item and is unlikely to move the stock.